insiderbuyingselling Posted - 6 days ago

$PTGX new insider selling: 1234 shares. http://insiderbuyingselling.com/?t=PTGX

RainbowTrump Posted - 1 week ago

$PTGX company has a collaborative agreement with $JNJ. Don’t see how people are comfortable to short this. Insane

RainbowTrump Posted - 2 weeks ago

$PTGX nice chart on the day. Volume about +50% of average

Aigner_Andreas Posted - 3 weeks ago

TF SELL $PTGX at 28.07 : 28.09 SmallCap 98% Shp 2.67 S 6.55 N 0.58 RSI 46.18% SRSI 22.82% ADXR 29.48 #stocks #trading #finance #market

insiderbuyingselling Posted - 3 weeks ago

$PTGX new insider selling: 25000 shares. http://insiderbuyingselling.com/?t=PTGX

EST51 Posted - 03/31/24

$PTGX

Aigner_Andreas Posted - 03/28/24

TF SELL $PTGX at 28.03 : 28.11 SmallCap 96% Shp 1.95 S 8.04 N 1.07 RSI 39.9% SRSI 0% ADXR 33.73 #stocks #trading #finance #market

G101SPM Posted - 03/27/24

$PTGX $28.34 bid. BUY/NEW LONG POSITION carries SPM 84.16 tag to $40.00 in midterm.

G101SPM Posted - 03/27/24

#SHOWTIME March 28, 2024 $KYMR, $PTGX, $VYNE H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference.

Stock_Titan Posted - 1 month ago

$PTGX Protagonist Therapeutics Provides Update on VERIFY Patient Enrollment and Timing of Top-line Data https://www.stocktitan.net/news/PTGX/protagonist-therapeutics-provides-update-on-verify-patient-sxw70w741fv7.html

Aigner_Andreas Posted - 1 month ago

TD BUY $PTGX at 28.82, Supp 28.35 Resis 32.15 R13 HiLo 82% T1Y 37 buy 1.7 DIV N/A #Protagonis #stocks #trading #finance #market

Stock_Titan Posted - 1 month ago

$PTGX Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda https://www.stocktitan.net/news/PTGX/protagonist-therapeutics-announces-closing-of-worldwide-rusfertide-a4vma4b2839x.html

RainbowTrump Posted - 1 month ago

$PTGX I think this will become a $90 stock

Stock_Titan Posted - 1 month ago

$PTGX Late-Breaking Presentation at American Academy of Dermatology 2024 Annual Meeting Shows that JNJ-2113, the First and Only Investigational Targeted Oral Peptide, Maintained Skin Clearance in Moderate-To-Severe Plaque Psoriasis Through One Year https://www.stocktitan.net/news/PTGX/late-breaking-presentation-at-american-academy-of-dermatology-2024-j9kjxzc82u6m.html

KSTom Posted - 1 month ago

$PHUN NICE! One of this four is PHUN! wopp woop! The other thre is $PTGX $AXGN $WDC 4 Must-Buy Stocks for Remarkable Earnings Acceleration the other thre is https://www.zacks.com/stock/news/2235092/4-must-buy-stocks-for-remarkable-earnings-acceleration?art_rec=quote-stock_overview-zacks_news-ID03-txt-2235092

Stock_Titan Posted - 1 month ago

$PTGX Protagonist Therapeutics to Participate in Upcoming Investor Conferences https://www.stocktitan.net/news/PTGX/protagonist-therapeutics-to-participate-in-upcoming-investor-e6dfchf6na8o.html

insiderbuyingselling Posted - 1 month ago

$PTGX new insider selling: 30000 shares. http://insiderbuyingselling.com/?t=PTGX

TG770 Posted - 1 month ago

$PTGX $AUPH Yup The same games are being played in Bio land over and over again.

Bretm50 Posted - 1 month ago

$PTGX $AUPH 💪 💪 This is how it's done Peter Greenleaf, get a fricking clue.

Bionco Posted - 02/28/24

$PTGX looking good . We're passing $30!

Thestocktraderhubzee Posted - 02/28/24

$PTGX JP Morgan Maintains Overweight on Protagonist Therapeutics, Raises Price Target to $37

Stock_Titan Posted - 02/27/24

$PTGX Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/PTGX/protagonist-reports-fourth-quarter-and-full-year-2023-financial-en32p27dz3jl.html

fda_tracker Posted - 02/27/24

$PTGX Phase 3 trial w/est Feb completion date NCT05210790: https://www.clinicaltrials.gov/study/NCT05210790 Trial Tracker: https://www.fdatracker.com/trial-tracker/

Stock_Titan Posted - 2 months ago

$PTGX New England Journal of Medicine Publishes Results of Positive Randomized Phase 2 REVIVE Trial of Rusfertide in Treatment of Polycythemia Vera https://www.stocktitan.net/news/PTGX/new-england-journal-of-medicine-publishes-results-of-positive-vnfcdetjh0pz.html

Stock_Titan Posted - 2 months ago

$PTGX Protagonist Therapeutics Reports Granting of Inducement Awards https://www.stocktitan.net/news/PTGX/protagonist-therapeutics-reports-granting-of-inducement-p8plnyza6kn8.html

techj2022 Posted - 2 months ago

$PTGX well financed after last deal . looks cheap. jnj big shareholder.

Fritter70 Posted - 2 months ago

$PTGX Low volume selling on the Takeda news the past three days, this will be back to $30 very soon.

valueforme Posted - 2 months ago

$PTGX This looks like a solid foundation to grow R&D further to IL-17 and beyond. Will be watching closer for a nonsense dip

Stock_Titan Posted - 2 months ago

$PTGX New England Journal of Medicine Publishes Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113 in a Phase 2b Moderate-To-Severe Plaque Psoriasis Study https://www.stocktitan.net/news/PTGX/new-england-journal-of-medicine-publishes-efficacy-and-safety-data-5qozp5r3fp72.html

Bradyshelton51 Posted - 2 months ago

$PTGX